Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean iodide i 10?
Displaying drugs 3126 - 3150 of 3759 in total

(1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid

(1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid is a solid. This compound belongs to the indole-3-acetic acid derivatives. These are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid is known to target interleukin-2.
Experimental

3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide

3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide is a solid. This compound belongs to the phenylmorpholines. These are aromatic compounds containing a morpholine ring and a benzene ring linked to each other through a CC or a CN bond. This drug targets mitogen-activated protein kinase 14.
Experimental

Rozrolimupab

Rozrolimupab is a recombinant polyclonal antibody consisting of 25 different anti-Rhesus D (RhD) antibodies to replace existing anti-RhD hyperimmune immunoglobulins for the treatment of Idiopathic Thrombocytopenic Purpura (ITP) and the prevention of Hemolytic Disease of Newborns (HDN).
Investigational

Bertilimumab

Bertilimumab is a fully human anti-eotaxin monoclonal antibody with potential in the treatment of allergic disorders, has moved into pre-clinical development. It is developed by MedImmune for the treatment of Allergic Rhinitis.
Investigational

Carbazochrome

Carbazochrome is a hemostatic agent that promotes clotting, preventing blood loss from open wounds. It is an oxidation product of adrenaline which enhances the microcirculatory tone . In the future this may prevent excessive blood flow during surgical operations and the treatment of hemorrhoids, but research on effectiveness and severity...
Experimental
Withdrawn

Roledumab

Roledumab is under investigation in clinical trial NCT02287896 (Pharmacokinetics and Safety of Roledumab in Rhd-negative Pregnant Women Carrying an Rhd-positive Foetus).
Investigational

Cotsiranib

Investigational

AB-201

AB-201 is a CAR-NK cell therapy targeted against HER2. It is under investigation for the treatment of HER2-positive cancers, including breast and gastric carcinomas.
Investigational

alpha-Ketoisovalerate

Experimental

JS-K

Investigational

1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane

Experimental

N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane

Experimental

(P-Iodophenylacetylamino)Methylphosphinic Acid

Experimental

2'-O-[1-ethyl-1H-imidazol)] thymidine-5'-monophosphate

Experimental

anti-alpha5Beta1-integrin antibody

Integrins are important adhesion molecules that regulate tumor and endothelial cell survival, proliferation and migration. The integrin alpha5beta1 has been shown to play a critical role during angiogenesis. anti-alpha5beta1 integrin antibody inhibits angiogenesis, including vessel formation induced by vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), as well...
Investigational

5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE

Experimental

(3S)-3-hydroxy-1-methyl-2,3-dihydro-1H-indole-5,6-dione

Experimental

3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID

Experimental

N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE

Experimental

Allogeneic human pancreatic islets of Langerhans

Investigational

Alrizomadlin

Alrizomadlin is a novel MDM2 inhibitor that blocks the interaction of MDM2 and p53. It is being investigated in cancers.[A257281,A257286]
Investigational

Tuvirumab

Investigational

Edobacomab

Investigational

S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea

Experimental

4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide

Experimental
Displaying drugs 3126 - 3150 of 3759 in total